These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35981407)

  • 1. The impact of COVID-19 on the epidemiology of non-airborne/droplet-transmitted notifiable infectious diseases in Taiwan: A descriptive study.
    Hung SH; Lin WT; Wang JH; Lai CC
    J Infect Public Health; 2022 Sep; 15(9):1001-1005. PubMed ID: 35981407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis.
    Lai CC; Chen SY; Yen MY; Lee PI; Ko WC; Hsueh PR
    Travel Med Infect Dis; 2021; 40():101997. PubMed ID: 33640476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.
    Tang HJ; Lai CC; Chao CM
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden changes in notifiable infectious diseases in Taiwan during the COVID-19 pandemic.
    Yang YF; Chen YM; Chen SY; Chiu PH; Chen SC
    PeerJ; 2024; 12():e18048. PubMed ID: 39267943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study.
    Liu W; Wang R; Li Y; Zhao S; Chen Y; Zhao Y
    BMC Public Health; 2023 Jun; 23(1):1089. PubMed ID: 37280569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence and Variation of the Indirect Effects of COVID-19 Restrictions on the Spectrum of Notifiable Infectious Diseases in China: Analysis of National Surveillance Among Children and Adolescents From 2018 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Miller JE; Dong Y; Song Y; Ma J; Sawyer S
    JMIR Public Health Surveill; 2024 May; 10():e47626. PubMed ID: 38748469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notifiable diseases after implementation of COVID-19 public health prevention measures in Central Queensland, Australia.
    Adegbija O; Walker J; Smoll N; Khan A; Graham J; Khandaker G
    Commun Dis Intell (2018); 2021 Feb; 45():. PubMed ID: 33632091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study.
    Xiao J; Dai J; Hu J; Liu T; Gong D; Li X; Kang M; Zhou Y; Li Y; Quan Y; He G; Zhong R; Zhu Z; Huang Q; Zhang Y; Huang J; Du Q; Li Y; Song T; Hu W; Zhong H; Ma W
    Lancet Reg Health West Pac; 2021 Dec; 17():100282. PubMed ID: 34611630
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic.
    Li K; Rui J; Song W; Luo L; Zhao Y; Qu H; Liu H; Wei H; Zhang R; Abudunaibi B; Wang Y; Zhou Z; Xiang T; Chen T
    Nat Commun; 2024 May; 15(1):3891. PubMed ID: 38719858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of common infectious diseases in Japan during the COVID-19 pandemic.
    Hibiya K; Iwata H; Kinjo T; Shinzato A; Tateyama M; Ueda S; Fujita J
    PLoS One; 2022; 17(1):e0261332. PubMed ID: 35020724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the coronavirus disease 2019 pandemic on the diversity of notifiable infectious diseases: a case study in Shanghai, China.
    Zhang Y; Feng W
    PeerJ; 2024; 12():e17124. PubMed ID: 38495754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the COVID-19 pandemic on chlamydia infection in South Korea: a comparison between the pre-pandemic and during-pandemic periods.
    Chiara A; Ryu S; Jung JH; Hwang SM
    Front Public Health; 2023; 11():1167321. PubMed ID: 37228722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the COVID-19 pandemic on infectious diseases reporting.
    Contarino F; Bella F; DI Pietro E; Randazzo C; Contrino ML
    J Prev Med Hyg; 2024 Jun; 65(2):E145-E153. PubMed ID: 39430999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of the COVID-19 pandemic on other infections differs by their route of transmission: A retrospective, observational study in Japan.
    Komori A; Mori H; Naito T
    J Infect Chemother; 2022 Dec; 28(12):1700-1703. PubMed ID: 36064143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of voluntary human mobility restrictions on vector-borne diseases during the COVID-19 pandemic in Japan: A descriptive epidemiological study using a national database (2016 to 2021).
    Hibiya K; Shinzato A; Iwata H; Kinjo T; Tateyama M; Yamamoto K; Fujita J
    PLoS One; 2023; 18(5):e0285107. PubMed ID: 37228070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1-2016 - week 32-2020.
    Ullrich A; Schranz M; Rexroth U; Hamouda O; Schaade L; Diercke M; Boender TS;
    Lancet Reg Health Eur; 2021 Jul; 6():100103. PubMed ID: 34557831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STIs during the COVID-19 Pandemic in Hungary: Gonorrhea as a Potential Indicator of Sexual Behavior.
    Lőrincz K; Meznerics FA; Jobbágy A; Kiss N; Madarász M; Belvon L; Tóth B; Tamási B; Wikonkál NM; Marschalkó M; Bánvölgyi A
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35954984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
    Rzymski P; Zarębska-Michaluk D; Parczewski M; Genowska A; Poniedziałek B; Strukcinskiene B; Moniuszko-Malinowska A; Flisiak R
    J Med Virol; 2024 May; 96(5):e29651. PubMed ID: 38712743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
    Pinto CN; Niles JK; Kaufman HW; Marlowe EM; Alagia DP; Chi G; Van Der Pol B
    Am J Prev Med; 2021 Sep; 61(3):386-393. PubMed ID: 34020848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the COVID-19 pandemic on sexually transmitted infections services - experience from Bialystok, Poland.
    Serwin AB; Kaczyńska J; Flisiak I
    Przegl Epidemiol; 2021; 75(2):151-158. PubMed ID: 34696547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.